---
title: "Addex Therapeutics surges over 8% in regular trading on heavy volume"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296644735.md"
description: "Addex Therapeutics (ADXN) surged over 8% in regular trading to $4.95, with volume hitting 7.12 million shares."
datetime: "2026-08-21T18:51:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296644735.md)
  - [en](https://longbridge.com/en/news/296644735.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296644735.md)
generator: "portal-rs"
---

# Addex Therapeutics surges over 8% in regular trading on heavy volume

Addex Therapeutics(ADXN.US) 盘中急涨，当日涨超 8%，现报 4.945 美元。

该股在盘中 5 分钟内连续触发急涨超 3% 及超 5% 信号，成交量达 711.69 万股。消息面暂无明显驱动。

### Related Stocks

- [ADXN.US](https://longbridge.com/en/quote/ADXN.US.md)

## Related News & Research

- [Addex says preclinical study shows mGlu7 inhibitor ADX71743 boosts wakefulness in rats](https://longbridge.com/en/news/292013939.md)
- [Addex shareholders approve all board proposals at AGM](https://longbridge.com/en/news/291226787.md)
- [ADXN: Net loss widened to CHF 1.7 million in Q1 2026; urgent funding needed beyond July 2026](https://longbridge.com/en/news/290779494.md)
- [Addex Reports Robust Preclinical Efficacy for Novel GABAB Modulator in Chronic Cough](https://longbridge.com/en/news/283442653.md)
- [Addex Reports Neurosterix On Track To Complete Phase 1 Trial For Schizophrenia Drug NTX-253](https://longbridge.com/en/news/283857819.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**